JP Morgan Chase’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
JP Morgan Chase's EXAS Position: Q1 2026 in Review
JP Morgan Chase sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 674,621 shares — an estimated $68.5M sold.
JP Morgan Chase first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $1.41B in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- JP Morgan Chase reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- JP Morgan Chase sold 674,621 Exact Sciences shares in Q1 2026, an estimated $68.5M.
- JP Morgan Chase first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
- JP Morgan Chase's Exact Sciences position peaked at $1.41B in Q2 2023.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.